Abstract
Low-grade gliomas and multiform glioblastoma are characterized by highly pronounced anaplasia, malignization, proliferation, and invasiveness; moreover, they are highly resistant to chemo- and radiotherapy. The very low efficiency of traditional approaches in the treatment of patients with glioblastomas is due to the intensive invasive growth of the tumor resulting in deep infiltration of adjacent normal perivascular and nervous tissue and formation of areas of perineural infiltration differently remote from the tumor epicenter. MicroRNAs are key posttranscriptional regulators of gene activities, and their expression is markedly increased in tumors, in particular in gliomas. MicroRNAs have been shown to promote the growth, proliferation, migration, and survival of tumor stem and non-stem cells. However, a population of microRNA possessing antitumor effects is also detected in gliomas. As a rule, the expression of antitumor microRNAs is suppressed in tumors. In this review, we consider microRNAs, their influence on radio- and chemoresistance of gliomas, and prospects for their use as specific agents in targeted therapy of gliomas. The pool of these microRNAs has distinct therapeutic value, because on use in combined therapy it can decrease the resistance of glioma tumor stem cells to existing pharmaceuticals and improve the efficiency of radio- and chemotherapy.
Similar content being viewed by others
Abbreviations
- ABC:
-
ATP-binding cassette carriers
- ABCB1 (MDR1):
-
multiple drug resistance protein 1
- ABCG2 (BCRP1):
-
ATP-binding cassette protein of G subfamily subunit 2
- AhR:
-
aryl hydrocarbon receptor
- AKT:
-
protein kinase B
- ATM:
-
protein kinase ATM
- Bax/Bcl-2:
-
Bcl2-associated protein X
- Bcl-2:
-
apoptosis regulator Bcl-2
- BRCA1:
-
protein responsible for DNA repair
- BRCA2:
-
protein responsible for repair of double-strain breaks
- Cdc25a:
-
phosphatase with double specificity
- c-Myc:
-
homolog of viral oncogene of avian myelocytomatosis V-myc
- CSA (ERCC8) and CSB (ERCC6):
-
excision repair proteins
- CXCR4:
-
chemokine receptor of type 4
- Dio3 :
-
gene encoding iodothyronine 5′-monoiodinase
- Dlk1 :
-
gene encoding δ-like protein-1
- DNA-PK:
-
DNA-dependent protein kinase
- EGFR:
-
epidermal growth factor receptor
- FEN1:
-
flap-endonuclease 1
- HIPK2:
-
homeodomain-inter-acting protein kinase 2
- Ku70 and Ku80:
-
parts of heterodimeric protein binding to DNA double-strand break ends
- Lig1 and Lig4:
-
DNA ligases 1 and 4, respectively
- L1CAM:
-
L1 cell adhesion molecule
- LRRFIP1 (leucine-rich repeat flightless-interacting protein 1):
-
cytosolic nucleic acid-binding protein
- MCF-7:
-
mammary gland carcinoma cell line
- MDR:
-
multiple drug resistance
- MDR3 (ABCB4):
-
multiple drug resistance protein
- MG:
-
multiform glioblastoma
- MRN:
-
a three-protein (Mre11-Rad50-Nbs1) DNA repair complex
- MVP (major vault protein):
-
a new multidrug resistance associated protein
- NF-κB:
-
nuclear factor κB
- Notch:
-
family of transmembrane proteins with repeated extracellular EGF and DSL domains
- p21/waf:
-
inhibitor of cyclin-dependent kinase
- PI3K:
-
phosphatidylinositol-3-kinase
- PTEN:
-
a dual-specificity protein phosphatase
- PXR:
-
pregnane X receptor
- RAD51:
-
homolog of RAD51 (S. cerevisiae) or homolog of RecA (E. coli)
- RAD52:
-
homolog of RAD52
- RAD54:
-
protein involved in chromatin remodeling
- RAD55 and RAD57:
-
proteins acting in complex with RAD51
- RFC:
-
replication factor C subunit-1
- SGF-1:
-
stromal growth factor-1
- shRNA:
-
short hairpin RNAs
- STAT-3:
-
signal transducers and transcription activator
- TGF-β:
-
transforming growth factor β
- TIMP3:
-
metalloproteinase inhibitor 3
- TSCs:
-
tumor stem cells
- XPA,B,C,D,G:
-
proteins involved in DNA repair
- XRCC4:
-
protein of DNA repair
- VEGF:
-
vascular endothelium growth factor
- VM-26:
-
teniposide
- VP-16:
-
etoposide
References
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., and Jouvet, A. (2007) Acta Neuropathol., 114, 97–109.
Stupp, R., Mason, W. P., Van Den Bent, M. J., Weller, M., Fisher, B., and Taphoorn, M. J. (2005) N. Engl. J. Med., 352, 987–996.
Eramo, A., Ricci-Vitiani, L., Zeuner, A., Pallini, R., Lotti, F., Sette, G., and Pilozzi, E. (2006) Cell Death Differ., 13, 1238–1241.
Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., and Hide, T. (2004) Nature, 432, 396–401.
Galli, R., Binda, E., Orfanelli, U., Cipelletti, B., Gritti, A., and De Vitis, S. (2004) Cancer Res., 64, 7011–7021.
Dirks, P. B., Philos Trans, R., and Soc Lond, B. (2008) Biol. Sci., 363, 139–152.
Cheng, J. X., Liu, B. L., and Zhang, X. (2009) Cancer Treat. Rev., 35, 403–408.
Beier, D., Hau, P., Proescholdt, M., Lohmeier, A., Wischhusen, J., and Oefner, P. J. (2007) Cancer Res., 67, 4010–4015.
Ogden, A. T., Waziri, A. E., Lochhead, R. A., Fusco, D., Lopez, K., and Ellis, J. A. (2008) Neurosurgery, 62, 505–514.
Clement, V., Dutoit, V., Marino, D., Dietrich, P. Y., and Radovanovic, I. (2009) Int. J. Cancer, 125, 244–248.
Oka, N., Soeda, A., Noda, S., and Iwama, T. (2009) Neurol. Med. Chir., 49, 146–151.
Thon, N., Damianoff, K., Hegermann, J., Grau, S., Krebs, B., and Schnell, O. (2010) Mol. Cell Neurosci., 43, 51–59.
Beier, D., Wischhusen, J., Dietmaier, W., Hau, P., Proescholdt, M., and Brawanski, A. (2008) Brain Pathol., 18, 370–377.
Rebetz, J., Tian, D., Persson, A., Widegren, B., Salford, L. G., and Englund, E. (2008) PLoS One, 3, e1936.
Zhang, M., Song, T., Yang, L., Chen, R., Wu, L., and Yang, Z. (2008) J. Exp. Clin. Cancer Res., 27, 85.
Ben-Baruch, A. (2009) Cell Adh. Migr., 3, 328–333.
Liu, G., Yuan, X., Zeng, Z., Tunici, P., Ng, H., and Abdulkadir, I. R. (2006) Mol. Cancer, 5, 67.
Salmaggi, A., Boiardi, A., Gelati, M., Russo, A., Calatozzolo, C., and Ciusani, E. (2006) Glia, 54, 850–860.
Tomuleasa, C., Soritau, O., Rus-Ciuca, D., Ioani, H., Susman, S., Petrescu, M., et al. (2010) J. BUON, 15, 583–591.
Schulte, A., Gunther, H. S., Phillips, H. S., Kemming, D., Martens, T., and Kharbanda, S. (2011) Glia, 59, 590–602.
Kang, M. K., and Kang, S. K. (2007) Stem Cell Dev., 16, 837–847.
Shervington, A., and Lu, C. (2008) Cancer Invest., 26, 535–542.
Nakai, E., Park, K., Yawata, T., Chihara, T., Kumazawa, A., and Nakabayashi, H. (2009) Cancer Invest., 27, 901–908.
Jin, F., Zhao, L., Guo, Y. J., Zhao, W. J., Zhang, H., and Wang, H. T. (2010) Brain Res., 1336, 103–111.
Angelastro, J. M., and Lame, M. W. (2010) Mol. Cancer Res., 8, 1105–1115.
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., and Hjelmeland, A. B. (2006) Nature, 444, 756–760.
He, J., Shan, Z., Li, L., Liu, F., Liu, Z., and Song, M. (2011) Oncol. Rep., 26, 1305–1313.
Bao, S., Wu, Q., Sathornsumetee, S., Hao, Y., Li, Z., and Hjelmeland, A. B. (2006) Cancer Res., 66, 7843–7848.
Ropolo, M., Daga, A., Griffero, F., Foresta, M., Casartelli, G., and Zunino, A. (2009) Mol. Cancer Res., 7, 383–392.
McCord, A. M., Jamal, M., Williams, E. S., Camphausen, K., and Tofilon, P. J. (2009) Clin. Cancer Res., 15, 5145–5153.
Bartel, D. P. (2004) Cell, 116, 281–297.
Yang, W., Lee, D. Y., and Ben-David, Y. (2011) Int. J. Physiol. Pathophysiol. Pharmacol., 3, 140–155.
Gonzalez-Gomez, P., Sanchez, P., and Mira, H. (2011) Mol. Neurobiol., 44, 235–249.
Turner, J. D., Williamson, R., Almefty, K. K., Nakaji, P., Porter, R., and Tse, V. (2010) Neurosurg. Focus., 28, E3.
Hagan, J. P., and Croce, C. M. (2007) Cytogenet. Genome Res., 118, 252–259.
Huang, P. H., Xu, A. M., and White, F. M. (2009) Sci. Signal, 2, re6.
Prasad, S., Ravindran, J., and Aggarwal, B. B. (2010) Mol. Cell Biochem., 336, 25–37.
Cancer Genome Atlas Research Network (2008) Nature, 455, 1061–1068.
Lawler, S., and Chiocca, E. A. (2009) J. Neurooncol., 92, 297–306.
Godlewski, J., Newton, H. B., Chiocca, E. A., and Lawler, S. E. (2010) Cell Death Differ., 17, 221–228.
Sana, J., Hajduch, M., Michalek, J., Vyzula, R., and Slaby, O. (2011) Cell Mol. Med., 15, 1636–1644.
Ciafre, S. A., Galardi, S., Mangiola, A., Ferracin, M., Liu, C. G., and Sabatino, G. (2005) Biochem. Biophys. Res. Commun., 334, 1351–1358.
Ferretti, E., De Smaele, E., Po, A., Di Marcotullio, L., Tosi, E., and Espinola, M. S. (2009) Int. J. Cancer, 124, 568–577.
Rao, S. A., Santosh, V., and Somasundaram, K. (2010) Mod. Pathol., 23, 1404–1417.
Lavon, I., Zrihan, D., Granit, A., Einstein, O., Fainstein, N., and Cohen, M. A. (2010) Neuro Oncol., 12, 422–433.
Hu, J., Jiang, C., Ng, H. K., Pang, J. C., and Tong, C. Y. (2002) Chin. Med. J. (Engl.), 115, 1201–1204.
Felsberg, J., Yan, P. S., Huang, T. H., Milde, U., Schramm, J., and Wiestler, O. D. (2006) Neuropathol. Appl. Neurobiol., 32, 517–524.
Al-Nedawi, K., Meehan, B., Micallef, J., Lhotak, V., May, L., and Guha, A. (2008) Nat. Cell Biol., 10, 619–624.
Antonyak, M. A., Li, B., Boroughs, L. K., Johnson, J. L., Druso, J. E., Bryant, K. L., and Holowka, D. A. (2011) Proc. Natl. Acad. Sci. USA, 108, 4852–4857.
Skog, J., Wurdinger, T., van Rijn, S., Meijer, D. H., Gainche, L., and Sena-Esteves, M. (2008) Nat. Cell Biol., 10, 1470–1476.
Graner, M. W., Alzate, O., Dechkovskaia, A. M., Keene, J. D., Sampson, J. H., and Mitchell, D. A. (2009) FASEB J., 23, 1541–1557.
Gagliano, N., Costa, F., Cossetti, C., Pettinari, L., Bassi, R., and Chiriva-Internati, M. (2009) Oncol. Rep., 22, 1349–1356.
Katakowski, M., Buller, B., Wang, X., Rogers, T., and Chopp, M. (2010) Cancer Res., 70, 8259–8263.
Valiunas, V., Polosina, Y. Y., Miller, H., Potapova, I. A., Valiuniene, L., and Doronin, S. (2005) J. Physiol., 568, 459–468.
Al-Nedawi, K., Meehan, B., and Rak, J. (2009) Cell Cycle, 8, 2014–2018.
Niemoeller, O. M., Niyazi, M., Corradini, S., Zehentmayr, F., Li, M., and Lauber, K. (2011) Radiat. Oncol., 6, 29.
Ding, J., Huang, S., Wu, S., Zhao, Y., Liang, L., and Yan, M. (2010) Nat. Cell Biol., 12, 390–399.
Qin, W., Shi, Y., Zhao, B., Yao, C., Jin L., Ma, J., and Jin, Y. (2010) PLoS One, 5, e9429.
Tian, S., Huang, S., Wu, S., Guo, W., Li, J., and He, X. (2010) Biochem. Biophys. Res. Commun., 396, 435–439.
Wild-Bode, C., Weller, M., Rimner, A., Dichgans, J., and Wick, W. (2001) Cancer Res., 61, 2744–2750.
Chaudhry, M. A., Sachdeva, H., and Omaruddin, R. A. (2010) DNA Cell Biol., 29, 553–561.
Lee, S. T., Chu, K., Oh, H. J., Im, W. S., Lim, J. Y., and Kim, S. K. (2010) DNA Cell Biol., 29, 553–561.
Ng, W. L., Yan, D., Zhang, X., Mo, Y. Y., and Wang, Y. (2010) DNA Repair (Amst.), 9, 1170–1175.
Lee, K. M., Choi, E. J., and Kim, I. A. (2011) Radiother. Oncol., 101, 171–176.
Kefas, B., Godlewski, J., Comeau, L., Li, Y., Abounader, R., and Hawkinson, M. (2008) Cancer Res., 68, 3566–3572.
Chen, G., Zhu, W., Shi, D., Lv, L., Zhang, C., and Liu, P. (2010) Oncol. Rep., 23, 997–1003.
Shi, L., Cheng, Z., Zhang, J., Li, R., Zhao, P., and Fu, Z. (2008) Brain Res., 1236, 185–193.
Papagiannakopoulos, T., Shapiro, A., and Kosik, K. S. (2008) Cancer Res., 68, 8164–8172.
Li, X., Pan, Y. Z., Seigel, G. M., Hu, Z. H., Huang, M., and Yu, A. M. (2011) Biochem. Pharmacol., 81, 783–792.
Lu, C., and Shervington, A. (2008) Mol. Cell Biochem., 312, 71–80.
Berger, W., Spiegl-Kreinecker, S., Buchroithner, J., Elbling, L., Pirker, C., and Fischer, J. (2001) Int. J. Cancer, 94, 377–382.
Aronica, E., Gorter, J. A., van Vliet, E. A., Spliet, W. G., van Veelen, C. W., and van Rijen, P. C. (2003) Epilepsia, 44, 1166–1175.
Dauchy, S., Dutheil, F., Weaver, R. J., Chassoux, F., Daumas-Duport, C., and Couraud, P. O. (2008) J. Neurochem., 107, 1518–1528.
Barnett, J. A., Urbauer, D. L., Murray, G. I., Fuller, G. N., and Heimberger, A. B. (2007) Clin. Cancer Res., 13, 3559–3567.
Wu, M. L., Li, H., Wu, D. C., Wang, X. W., Chen, X. Y., and Kong, Q. Y. (2005) Neurosci. Lett., 384, 33–37.
Shimada, T., Hayes, C. L., Yamazaki, H., Amin, S., Hecht, S. S., and Guengerich, F. P. (2004) Cancer Sci., 95, 1–6.
Patterson, L. H., and Murray, G. I. (2002) Curr. Pharm. Des., 8, 1335–1347.
Tsuchiya, Y., Nakajima, M., Takagi, S., Taniya, T., and Yokoi, T. (2006) Cancer Res., 66, 9090–9098.
Bruno, R. D., and Njar, V. C. (2007) Bioorg. Med. Chem., 15, 5047–5060.
Kirches, E., Scherlach, C., von Bossanyi, P., Schneider, T., Szibor, R., and Kutz, E. (1999) Clin. Neuropathol., 18, 1–8.
Lu, H., and Waxman, D. J. (2005) Mol. Pharmacol., 67, 212–219.
Iwamoto, F. M., Lamborn, K. R., Kuhn, J. G., Wen, P. Y., Yung, W. K., and Gilbert, M. R. (2011) Neurooncology, 13, 509–516.
Urquhart, B. L., Tirona, R. G., and Kim, R. B. (2007) J. Clin. Pharmacol., 47, 566–578.
Takagi, S., Nakajima, M., Mohri, T., and Yokoi, T. (2008) J. Biol. Chem., 283, 9674–9680.
Mohri, T., Nakajima, M., Takagi, S., Komagata, S., and Yokoi, T. (2009) J. Cancer, 125, 1328–1333.
Pan, Y. Z., Gao, W., and Yu, A. M. (2009) Drug Metab. Dispos., 37, 2112–2117.
Chen, T. (2010) Adv. Drug Deliv. Rev., 62, 1257–1264.
Zhu, H., Wu, H., Liu, X., Evans, B. R., Medina, D. J., and Liu, C. G. (2008) Biochem. Pharmacol., 76, 582–588.
Li, Z., Hu, S., Wang, J., Cai, J., Xiao, L., Yu, L., and Wang, Z. (2010) Gynecol. Oncol., 119, 125–130.
An, Y., and Ongkeko, W. M. (2010) Oncol. Rep., 23, 997–1003.
Lopez, J. P., Wang-Rodriguez, J., Chang, C., Chen, J. S., Pardo, F. S., and Aguilera, J. (2007) Arch. Otolaryngol. Head Neck Surg., 133, 1022–1027.
Li, W. Q., Li, Y. M., Tao, B. B., Lu, Y. C., Hu, G. H., and Liu, H. M. (2010) Med. Sci. Monit., 16, HY27–30.
Pan, Y. Z., Morris, M. E., and Yu, A. M. (2009) Mol. Pharmacol., 75, 1374–1379.
To, K. K., Robey, R. W., Knutsen, T., Zhan, Z., Ried, T., and Bates, S. E. (2009) Mol. Cancer. Ther., 8, 2959–2968.
Wang, F., Xue, X., Wei, J., An, Y., Yao, J., and Cai, H. (2010) Br. J. Cancer, 103, 567–574.
Li, Y., Li, W., Yang, Y., Lu, Y., He, C., and Hu, G. (2009) Brain Res., 1286, 13–18.
Pradhan, M., Bembinster, L. A., Baumgarten, S. C., and Frasor, J. (2010) J. Biol. Chem., 285, 31100–31106.
Ren, Y., Zhou, X., Mei, M., Yuan, X. B., Han, L., and Wang, G. X. (2010) BMC Cancer, 10, 27.
Herlevsen, M., Oxford, G., Ptak, C., Shabanowitz, J., Hunt, D. F., and Conaway, M. (2007) Biochem. Biophys. Res. Commun., 352, 549–555.
Shi, L., Chen, J., Yang, J., Pan, T., Zhang, S., and Wang, Z. (2010) Brain Res., 1352, 255–264.
Zhou, X., Zhang, J., Jia, Q., Ren, Y., Wang, Y., and Shi, L. (2010) Oncol. Rep., 24, 195–201.
Ujifuku, K., Mitsutake, N., Takakura, S., Matsuse, M., Saenko, V., and Suzuki, K. (2010) Cancer Lett., 296, 241–248.
Moser, J. J., and Fritzler, M. J. (2010) PLoS One, 5, e13445.
Qi, J., Yu, J. Y., Shcherbata, H. R., Mathieu, J., Wang, A. J., and Seal, S. (2009) Cell Cycle, 8, 3729–3741.
Jiang, G., Wei, Z. P., Pei, D. S., Xin, Y., Liu, Y. Q., and Zheng, J. N. (2011) Biochem. Biophys. Res. Commun., 406, 311–314.
Ren, Y., Kang, C. S., Yuan, X. B., Zhou, X., Xu, P., and Han, L. (2010) J. Biomater. Sci. Polym. Ed., 21, 303–314.
Li, Y., Zhao, S., Zhen, Y., Li, Q., Teng, L., and Asai, A. (2011) Brain Tumor Pathol., 28, 209–214.
Bao, S., Wu, Q., Li, Z., Sathornsumetee, S., Wang, H., and McLendon, R. E. (2008) Cancer Res., 68, 6043–6048.
Wang, H., Lathia, J. D., Wu, Q., Wang, J., Li, Z., and Heddleston, J. M. (2009) Stem Cells, 27, 2393–2404.
Wang, J., Wang, H., Li, Z., Wu, Q., Lathia, J. D., and McLendon, R. E. (2008) PLoS One, 3, e3769.
Suva, M. L., Riggi, N., Janiszewska, M., Radovanovic, I., Provero, P., and Stehle, J. C. (2009) Cancer Res., 69, 9211–9218.
Hjelmeland, A. B., Wu, Q., Wickman, S., Eyler, C., Heddleston, J., and Shi, Q. (2010) PLoS Biol., 8, e1000319.
Wang, P., Rao, J., Yang, H., Zhao, H., and Yang, L. J. (2011) Huazhong. Univ. Sci. Technol. Med. Sci., 31, 94–99.
Chekhonin, V. P., Tsibulkina, E. A., Ryabinina, A. E., Zhirkov, Y. A., Savchenko, E. A., and Shvets, V. I. (2008) Byul. Eksp. Biol. Med., 146, 451–454.
Chekhonin, V. P., Gurina, O. I., Ykhova, O. V., Ryabinina, A. E., Tsibulkina, E. A., and Zhirkov, Y. A. (2008) Byul. Eksp. Biol. Med., 145, 449–451.
Chekhonin, V. P., Baklaushev, V. P., Yusubalieva, G. M., and Gurina, O. I. (2009) J. Neuroimmune Pharmacol., 4, 28–34.
Chekhonin, V. P., Baklaushev, V. P., Yusubalieva, G. M., Belorusova, A. E., Gulyaev, M. V., and Tsitrin, E. B. (2012) Nanomedicine, 8, 63–70.
Wu, C., Lin, J., Hong, M., Choudhury, Y., Balani, P., and Leung, D. (2009) Mol. Ther., 17, 2058–2066.
Shen, Q., Wang, Y., Kokovay, E., Lin, G., Chuang, S. M., and Goderie, S. K. (2008) Cell Stem Cell, 3, 289–300.
Calabrese, C., Poppleton, H., Kocak, M., Hogg, T. L., Fuller, C., and Hamner, B. (2007) Cancer Cell, 11, 69–82.
Folkins, C., Shaked, Y., Man, S., Tang, T., Lee, C. R., and Zhu, Z. (2009) Cancer Res., 69, 7243–7251.
Folkins, C., Man, S., Xu, P., Shaked, Y., Hicklin, D. J., and Kerbel, R. S. (2007) Cancer Res., 67, 3560–3564.
Meister, J., and Schmidt, M. H. (2010) Sci. World J., 10, 2090–2100.
Cascio, S., D’Andrea, A., Ferla, R., Surmacz, E., Gulotta, E., and Amodeo, V. (2010) J. Cell Physiol., 224, 242–249.
Jafarifar, F., Yao, P., Eswarappa, S. M., and Fox, P. L. (2011) EMBO J., 30, 1324–3134.
Liu, L. Z., Li, C., Chen, Q., Jing, Y., Carpenter, R., and Jiang, Y. (2011) PLoS One, 6, e19139.
Wurdinger, T., Tannous, B. A., Saydam, O., Skog, J., Grau, S., and Soutschek, J. (2008) Cancer Cell, 14, 382–393.
Dey, M., Ulasov, I. V., and Lesniak, M. S. (2010) Cancer Lett., 289, 1–10.
Markert, J. M., Liechty, P. G., Wang, W., Gaston, S., Braz, E., and Karrasch, M. (2009) Mol. Ther., 17, 199–207.
Kambara, H., Okano, H., Chiocca, E. A., and Saeki, Y. (2005) Cancer Res., 65, 2832–2839.
Han, Z. Q., Assenberg, M., Liu, B. L., Wang, Y. B., Simpson, G., and Thomas, S. (2007) J. Gene Med., 9, 99–106.
Liu, T. C., Zhang, T., Fukuhara, H., Kuroda, T., Todo, T., and Martuza, R. L. (2006) Mol. Ther., 14, 789–797.
Hardcastle, J., Kurozumi, K., Dmitrieva, N., Sayers, M. P., Ahmad, S., Waterman, P., Weissleder, R., Chiocca, E. A., and Kaur, B. (2010) Mol. Ther., 18, 285–294.
Anesti, A. M., Simpson, G. R., Price, T., Pandha, H. S., and Coffin, R. S. (2010) BMC Cancer, 10, 486.
Dembinski, J. L., Spaeth, E. L., Fueyo, J., Gomez-Manzano, C., Studeny, M., and Andreeff, M. (2010) Cancer Gene Ther., 17, 289–297.
Sonabend, A. M., Ulasov, I. V., Tyler, M. A., Rivera, A. A., Mathis, J. M., and Lesniak, M. S. (2008) Stem Cells, 26, 831–841.
Yong, R. L., Shinojima, N., Fueyo, J., Gumin, J., Vecil, G. G., and Marini, F. C. (2009) Cancer Res., 69, 8932–8940.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © Ph. A. Koshkin, D. A. Chistiakov, V. P. Chekhonin, 2013, published in Biokhimiya, 2013, Vol. 78, No. 4, pp. 429–441.
Rights and permissions
About this article
Cite this article
Koshkin, P.A., Chistiakov, D.A. & Chekhonin, V.P. Role of microRNAs in mechanisms of glioblastoma resistance to radio- and chemotherapy. Biochemistry Moscow 78, 325–334 (2013). https://doi.org/10.1134/S0006297913040019
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006297913040019